NASDAQ:GEVO Gevo (GEVO) Stock Forecast, Price & News $1.21 -0.07 (-5.47%) (As of 03:34 PM ET) Add Compare Share Share Today's Range$1.21▼$1.2950-Day Range$1.28▼$1.7752-Week Range$1.01▼$2.58Volume2.86 million shsAverage Volume5.44 million shsMarket Capitalization$287.25 millionP/E RatioN/ADividend YieldN/APrice Target$4.79 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Gevo MarketRank™ ForecastAnalyst RatingHold2.40 Rating ScoreUpside/Downside286.3% Upside$4.79 Price TargetShort InterestBearish15.27% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$799,055 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($0.26) to ($0.28) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.77 out of 5 starsOils/Energy Sector186th out of 237 stocksIndustrial Organic Chemicals Industry14th out of 19 stocks 3.2 Analyst's Opinion Consensus RatingGevo has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.79, Gevo has a forecasted upside of 286.3% from its current price of $1.24.Amount of Analyst CoverageGevo has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted15.27% of the outstanding shares of Gevo have been sold short.Short Interest Ratio / Days to CoverGevo has a short interest ratio ("days to cover") of 8.4.Change versus previous monthShort interest in Gevo has recently decreased by 2.08%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldGevo does not currently pay a dividend.Dividend GrowthGevo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GEVO. Previous Next 2.2 News and Social Media Coverage News SentimentGevo has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Oils/Energy companies.Search InterestOnly 45 people have searched for GEVO on MarketBeat in the last 30 days. This is a decrease of -2% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Gevo to their MarketBeat watchlist in the last 30 days. This is a decrease of -45% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Gevo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $799,055.00 in company stock.Percentage Held by InsidersOnly 3.55% of the stock of Gevo is held by insiders.Percentage Held by InstitutionsOnly 39.26% of the stock of Gevo is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Gevo are expected to decrease in the coming year, from ($0.26) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Gevo is -2.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Gevo is -2.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGevo has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Gevo (NASDAQ:GEVO) StockGevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.Read More GEVO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GEVO Stock News HeadlinesSeptember 12, 2023 | finance.yahoo.comColorado energy producer pursues federal loan for $950M biofuel project, delays startSeptember 11, 2023 | msn.comAnalysis: Summit denial might not last as a winSeptember 21, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.September 6, 2023 | markets.businessinsider.comH.C. Wainwright Remains a Buy on Gevo (GEVO)September 6, 2023 | msn.comGevo gets $30M grant from USDASeptember 6, 2023 | financialpost.comGevo and U.S. Department of Agriculture Sign Agreement Providing Gevo a Grant to Incentivize, Track, and Verify Acreage of Low-Carbon Corn to Accelerate Production of Sustainable Aviation Fuel (SAF) and Other BiofuelsSeptember 1, 2023 | msn.comDragon Ball: The Gero Family Tree, ExplainedAugust 31, 2023 | msn.comGevo (GEVO) Price Target Increased by 135.79% to 4.57September 21, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.August 22, 2023 | msn.comNorthland Capital Markets Initiates Coverage of Gevo (GEVO) with Market Perform RecommendationAugust 18, 2023 | finance.yahoo.comThe past five years for Gevo (NASDAQ:GEVO) investors has not been profitableAugust 15, 2023 | finance.yahoo.comDr. Patrick Gruber to Participate in a Water Tower Research Fireside Chat on Thursday, August 17th at 4:00 pm ETAugust 11, 2023 | finanznachrichten.deGevo, Inc.: Gevo Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | finance.yahoo.comGevo Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | markets.businessinsider.comGevo (GEVO) Receives a Rating Update from a Top AnalystAugust 11, 2023 | msn.comHC Wainwright & Co. Maintains Gevo (GEVO) Buy RecommendationAugust 7, 2023 | msn.comGevo's Net-Zero 1 project moves to due diligence phase for DoE loan guaranteeAugust 7, 2023 | finance.yahoo.comGevo’s Net-Zero 1 Reaches Key Milestone for Loan Guarantee from the U.S. Department of EnergyAugust 2, 2023 | finance.yahoo.com3 Millionaire-Maker Growth Stocks to Buy Before the WindowJuly 26, 2023 | bizjournals.comTexas companies, projects soar in sustainable aviation fuel industry, report saysJuly 24, 2023 | seekingalpha.comGevo, McDermott team up to develop sustainable aviation fuel facilitiesJuly 24, 2023 | finanznachrichten.deGevo, Inc.: Gevo Signs Master Services Agreement with McDermott for Sustainable Aviation Fuel FacilitiesJuly 24, 2023 | marketwatch.comGevo Signs Engineering Services Deal with McDermott for Planned SAF Plants -- OPISJuly 24, 2023 | financialpost.comGevo Signs Master Services Agreement with McDermott for Sustainable Aviation Fuel FacilitiesJuly 13, 2023 | finance.yahoo.comGevo, Inc. to Report Second Quarter 2023 Financial Results on August 10, 2023July 6, 2023 | msn.comGevo (GEVO) Price Target Decreased by 5.26% to 1.84June 25, 2023 | msn.comRisk Vs. Reward: Exploring The Potential In GevoSee More Headlines Receive GEVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gevo and its competitors with MarketBeat's FREE daily newsletter. Email Address GEVO Company Calendar Last Earnings8/10/2023Today9/21/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Industrial organic chemicals Sub-IndustryOil & Gas Refining & Marketing SectorOils/Energy Current SymbolNASDAQ:GEVO CUSIP37439610 CIK1392380 Webwww.gevo.com Phone(303) 858-8358FaxN/AEmployees87Year Founded2005Price Target and Rating Average Stock Price Forecast$4.79 High Stock Price Forecast$14.00 Low Stock Price Forecast$2.00 Forecasted Upside/Downside+268.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-98,010,000.00 Net Margins-1,105.89% Pretax Margin-1,105.89% Return on Equity-16.82% Return on Assets-14.49% Debt Debt-to-Equity RatioN/A Current Ratio4.79 Quick Ratio4.74 Sales & Book Value Annual Sales$1.17 million Price / Sales263.51 Cash FlowN/A Price / Cash FlowN/A Book Value$2.55 per share Price / Book0.51Miscellaneous Outstanding Shares237,400,000Free Float228,975,000Market Cap$308.31 million OptionableOptionable Beta3.12 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Patrick R. Gruber M.B.A. (Age 62)MBA, Ph.D., CEO & Director Comp: $926.15kDr. Christopher M. Ryan (Age 62)Pres & COO Comp: $570.62kMr. L. Lynn Smull (Age 62)Chief Financial Officer Comp: $477kMr. Timothy J. Cesarek (Age 59)Chief Commercial Officer Comp: $477kDr. Paul D. Bloom (Age 49)Chief Carbon Officer & Chief Innovation Officer Comp: $432kProf. James C. Liao Ph.D.Co-FounderMr. Alisher Nurmat CPA (Age 53)Principal Accounting Officer, VP & Controller Ms. Heather L. ManuelVP of Corp. CommunicationsMs. Kimberly T. Bowron SPHR (Age 53)Chief People Officer Mr. David A. GeorgeSr. VP of Verity TrackingMore ExecutivesKey CompetitorsREX American ResourcesNYSE:REXFutureFuelNYSE:FFOrigin MaterialsNASDAQ:ORGNAemetisNASDAQ:AMTXVerde Clean FuelsNASDAQ:VGASView All CompetitorsInsiders & InstitutionsPatrick R GruberSold 171,549 sharesTotal: $236,737.62 ($1.38/share)Christopher Michael RyanSold 83,902 sharesTotal: $115,784.76 ($1.38/share)L Lynn SmullSold 72,764 sharesTotal: $100,414.32 ($1.38/share)Andrew MarshSold 16,750 sharesTotal: $23,115.00 ($1.38/share)Kimberly T BowronSold 15,071 sharesTotal: $20,797.98 ($1.38/share)View All Insider TransactionsView All Institutional Transactions GEVO Stock - Frequently Asked Questions Should I buy or sell Gevo stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Gevo in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GEVO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GEVO, but not buy additional shares or sell existing shares. View GEVO analyst ratings or view top-rated stocks. What is Gevo's stock price forecast for 2023? 5 brokerages have issued 1-year price objectives for Gevo's stock. Their GEVO share price forecasts range from $2.00 to $14.00. On average, they anticipate the company's share price to reach $4.79 in the next year. This suggests a possible upside of 268.8% from the stock's current price. View analysts price targets for GEVO or view top-rated stocks among Wall Street analysts. How have GEVO shares performed in 2023? Gevo's stock was trading at $1.90 at the beginning of 2023. Since then, GEVO stock has decreased by 31.6% and is now trading at $1.2987. View the best growth stocks for 2023 here. When is Gevo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our GEVO earnings forecast. How were Gevo's earnings last quarter? Gevo, Inc. (NASDAQ:GEVO) issued its quarterly earnings results on Thursday, August, 10th. The energy company reported ($0.06) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.06). The energy company had revenue of $4.24 million for the quarter, compared to the consensus estimate of $4.39 million. Gevo had a negative net margin of 1,105.89% and a negative trailing twelve-month return on equity of 16.82%. During the same period in the prior year, the company earned ($0.06) earnings per share. What ETFs hold Gevo's stock? ETFs with the largest weight of Gevo (NASDAQ:GEVO) stock in their portfolio include WisdomTree BioRevolution Fund (WDNA), Invesco Global Clean Energy ETF (PBD), Invesco Nasdaq Future Gen 200 ETF (QQQS), ALPS Clean Energy ETF (ACES), Global X Renewable Energy Producers ETF (RNRG) and VanEck Green Infrastructure ETF (RNEW). When did Gevo's stock split? Shares of Gevo reverse split on Monday, June 4th 2018. The 1-20 reverse split was announced on Friday, June 1st 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 1st 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What is Patrick Gruber's approval rating as Gevo's CEO? 7 employees have rated Gevo Chief Executive Officer Patrick Gruber on Glassdoor.com. Patrick Gruber has an approval rating of 15% among the company's employees. This puts Patrick Gruber in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Gevo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Gevo investors own include Bionano Genomics (BNGO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Denison Mines (DNN), Novan (NOVN) and CBL & Associates Properties (CBL). What is Gevo's stock symbol? Gevo trades on the NASDAQ under the ticker symbol "GEVO." Who are Gevo's major shareholders? Gevo's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.13%), State Street Corp (4.99%), Geode Capital Management LLC (1.94%), Northern Trust Corp (0.80%), Baird Financial Group Inc. (0.69%) and Nuveen Asset Management LLC (0.38%). Insiders that own company stock include Alisher K Nurmat, Andrew Marsh, Christopher Michael Ryan, Gary W Mize, Geoffrey Thomas Jr Williams, Kimberly T Bowron, L Lynn Smull, Patrick R Gruber, Paul D Bloom and Timothy J Cesarek. View institutional ownership trends. How do I buy shares of Gevo? Shares of GEVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Gevo's stock price today? One share of GEVO stock can currently be purchased for approximately $1.30. How much money does Gevo make? Gevo (NASDAQ:GEVO) has a market capitalization of $308.31 million and generates $1.17 million in revenue each year. The energy company earns $-98,010,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. How can I contact Gevo? Gevo's mailing address is 345 Inverness Drive South Building C Suite 310, Englewood CO, 80112. The official website for the company is www.gevo.com. The energy company can be reached via phone at (303) 858-8358 or via email at info@integra-ir.com. This page (NASDAQ:GEVO) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gevo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.